Redefining fatty liver disease classification in 2020 - PubMed (original) (raw)

Editorial

. 2020 May;40(5):1016-1017.

doi: 10.1111/liv.14430.

Affiliations

Free article

Editorial

Redefining fatty liver disease classification in 2020

Luca Valenti et al. Liver Int. 2020 May.

Free article

No abstract available

Keywords: diabetes; fatty liver disease; genetics; metabolism; steatosis.

The amount of liver fat predicts mortality and development of type 2 diabetes in non-alcoholic fatty liver disease.
Nasr P, Fredrikson M, Ekstedt M, Kechagias S. Nasr P, et al. Liver Int. 2020 May;40(5):1069-1078. doi: 10.1111/liv.14414. Epub 2020 Mar 10. Liver Int. 2020. PMID: 32087038

1. Younossi Z, Anstee QM, Marietti M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15(1):11-20.
1. Estes C, Anstee QM, Arias-Loste MT, et al. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030. J Hepatol. 2018;69(4):896-904.
1. Pelusi S, Valenti L. Hepatic fat as clinical outcome and therapeutic target for nonalcoholic fatty liver disease. Liver Int. 2019;39(2):250-256.
1. Romeo S, Sanyal A, Valenti L. Leveraging human genetics to identify potential new treatments for fatty liver disease. Cell Metab. 2020;31(1):35-45.
1. Yuan J, Chen C, Cui J, et al. Fatty liver disease caused by high-alcohol-producing klebsiella pneumoniae. Cell Metab. 2019;30(4):pp. 675-88 e7.